Pulmonary Fibrosis Foundation Community Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-11

Study Completion Date

2027-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary Fibrosis Foundation Community Registry will offer an online portal where participants can self-enroll and directly contribute information about their experience with PF to be compiled into a longitudinal data set for use by researchers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulmonary Fibrosis Foundation Patient Registry

NCT02758808

Interstitial Lung Disease (ILD) Idiopathic Pulmonary Fibrosis (IPF)

COMPLETED

Pulmonary Fibrosis Contact Registry

NCT01935726

Pulmonary Fibrosis of Any Cause Primary Supporters/Caretakers of Patients With Pulmonary Fibrosis

COMPLETED

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

NCT01915511

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

RECRUITING

Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry

NCT00212511

Idiopathic Pulmonary Fibrosis

WITHDRAWN

Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry

NCT00540475

Idiopathic Pulmonary Fibrosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The PFF Community Registry is an observational, longitudinal cohort study. The Community Registry will enroll three different cohort groups:

1. Patients with PF, including those who are post lung transplant
2. Caregivers of patients with PF
3. Family members of patients with PF

This is an online registry open to individuals affected by PF in the US. It is not associated with a physical location or institution. Individuals may self-enroll online and contribute data to the Community Registry by answering a series of surveys at regular intervals.

Participants may also elect to be contacted about future research projects through the PFF Community Registry portal. However, this is not required to participate in the Community Registry itself.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Fibrosis Interstitial Lung Disease Lung Fibrosis Idiopathic Pulmonary Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

An individual diagnosed with PF or ILD, including those who are post lung transplant.

No interventions assigned to this group

Family Members

A family member (defined as biological parent, full or half-sibling, or biological child) of an individual with PF or ILD.

No interventions assigned to this group

Caregivers

An individual who has cared (currently or in the past) for an individual with PF or ILD.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

1. Provision of signed and dated informed consent form online
2. Male or female, aged 18 or older
3. Affected by PF as a member of at least one of the following cohorts:

1. An individual diagnosed with PF or ILD, including those who are post lung transplant, or
2. An individual who has cared (currently or in the past) for an individual with PF or ILD, and / or
3. A family member (defined as parent, full or half-sibling, or child) of an individual with PF or ILD.
4. Has internet access and a valid email address.

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

1. Primary residence or place of care is outside of the US.
2. Inability or unwillingness of a participant to provide informed consent or comply with study protocol.
3. Any condition or circumstance not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
4. Patients who were diagnosed with any of the below lung diseases. Similarly caregivers and family members associated with these diseases would be excluded.

* Sarcoid
* Lymphangioleiomyomatosis (LAM)
* Pulmonary alveolar proteinosis (PAP)
* Cystic fibrosis (CF)
* Amyloidosis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes